This inventor holds 1 USPTO granted patent. Top assignee: Korea Institute of Science and Technology. Active years: 2000.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2000
Title: Innovations of Jun-Sung Lee in Cholesterol Management
Introduction
Jun-Sung Lee is a notable inventor based in Daejeon, South Korea. He has made significant contributions to the field of cholesterol management through his innovative research. His work focuses on the use of natural compounds to inhibit harmful processes in the body.
Latest Patents
Jun-Sung Lee holds a patent for "Naringin and naringenin as inhibitors of acyl - Methods for inhibiting the activity of acyl CoA-cholesterol-o-acyltransferase." This invention aims to inhibit the accumulation of macrophage-lipid complex on the arterial endothelium and prevent or treat hepatic diseases in mammals. The patent highlights the potential of naringin and naringenin as effective agents in managing cholesterol levels.
Career Highlights
He is affiliated with the Korea Institute of Science and Technology, where he conducts his research. His work has garnered attention for its innovative approach to addressing health issues related to cholesterol.
Collaborations
Jun-Sung Lee collaborates with esteemed colleagues, including Song-Hae Bok and Tae-Sook Jeong. Their combined expertise enhances the research and development of effective treatments.
Conclusion
Jun-Sung Lee's contributions to the field of cholesterol management through his innovative patent demonstrate the potential of natural compounds in medical applications. His work continues to pave the way for advancements in health and wellness.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile